---
title: "Rituximab (MabThera) Subcutaneous Vial"
ocid: "ocds-r6ebe6-0000621914"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000621914"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000621914.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000621914.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2020-07-07"
---

# Rituximab (MabThera) Subcutaneous Vial

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000621914

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000621914)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000621914.json)

## Summary

The procurement process is led by The Common Services Agency (NHS National Services Scotland), located in Edinburgh, UK. The tender, titled "Rituximab (MabThera) Subcutaneous Vial," falls under the health industry category and involves the supply of rituximab subcutaneous vials to NHS Scotland. The awarding stage is complete, with key dates including the contract being signed on 28 May 2020. The procurement method used was a limited award procedure without prior publication, based on the protection of intellectual property rights associated with the medicine.

This tender presents significant opportunities for businesses that specialise in pharmaceuticals and medical supplies, particularly those capable of supplying specialised products under framework agreements. Given the nature of the procurement, larger firms or those with substantial experience in dealing with NHS contracts would be well-positioned to compete effectively. Companies interested in expanding their presence in the healthcare sector may particularly benefit from this contract, which has an estimated total value of £13,728,768 and is designed for a two-year initial term, with the possibility of extension.

## Notice

The supply of rituximab (MabThera) subcutaneous vials to NHS Scotland.

### Lot Information

Lot 1

The supply of rituximab subcutaneous vials to NHS Scotland.

### Procurement Information

The medicine awarded to this framework is, and will remain to be, protected by patent for the duration of the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL389906 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 7 Jul 2020 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 28 May 2020 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £13,728,768 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 7 Jul 2020 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL389906
- 28 May 2020 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN387318

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN387318
  Rituximab (MabThera) Subcutaneous Vial - The supply of rituximab (MabThera) subcutaneous vials to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL389906
  Rituximab (MabThera) Subcutaneous Vial - The supply of rituximab (MabThera) subcutaneous vials to NHS Scotland.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000621914

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000621914. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000621914.json.